Protect Infant Formula from Contamination Act
Latest Action
Held at the desk.
Official Summary
Protect Infant Formula from Contamination Act This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.
GovScope Watchdog™
AI Government Intelligence™The Protect Infant Formula from Contamination Act (S. 272) is a Senate bill introduced in the 119th Congress aimed at addressing the safety and contamination risks associated with infant formula. As of the latest update, the bill is in process but lacks a publicly available official summary or full text. The most recent procedural action was that the bill was held at the desk on May 4, 2026. Due to the absence of detailed legislative text and summary, specific provisions, enforcement mechanisms, and funding details are not available for analysis.
S. 272 is a Senate bill focused on preventing contamination in infant formula, currently pending further legislative action with limited publicly available details.
- The bill is titled the Protect Infant Formula from Contamination Act and was introduced in the Senate during the 119th Congress.
- No official summary or full text is publicly available, limiting detailed analysis of its provisions.
- The latest recorded legislative action was the bill being held at the desk on May 4, 2026, indicating it has not progressed to committee or floor consideration.
['Infants and families relying on infant formula', 'Regulatory agencies responsible for food safety', 'Manufacturers and distributors of infant formula']
['Lack of publicly available full text and summary limits understanding of implementation requirements and enforcement mechanisms.', 'Unclear funding sources or budgetary impacts for regulatory oversight or compliance.', 'Potential challenges in defining contamination standards and monitoring protocols without detailed legislative language.']
The bill was introduced in the Senate during the 119th Congress and is currently in process but has not advanced beyond being held at the desk. There is no publicly available information on committee referrals, sponsors, or legislative debate. The absence of a summary and full text suggests the bill may be in early stages or awaiting further development.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased regulatory scrutiny on infant formula production and distribution if the bill includes new contamination prevention standards.', 'Possible impact on manufacturing costs and supply chain processes depending on the stringency of contamination controls.', 'Enhanced consumer confidence in infant formula safety if effective contamination prevention measures are implemented.']
The lack of publicly available bill text and summary limits the ability to conduct a thorough transparency and oversight analysis. Monitoring future updates for release of the full legislative text and detailed summaries will be essential for evaluating the bill's provisions, funding, and enforcement mechanisms. The current status of being held at the desk suggests limited legislative movement, which may affect stakeholder engagement and public awareness.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.